A novel mode of FoxM1 regulation: positive auto-regulatory loop.
Marianna Halasi, Andrei L Gartel
Index: Cell Cycle 8(12) , 1966-7, (2009)
Full Text: HTML
Abstract
Oncogenic transcription factor FoxM1 represents an attractive therapeutic target in the fight against cancer, because it is overexpressed in a majority of human tumors. Previously, we identified the thiazole antibiotics as potent inhibitors of FoxM1. Surprisingly, investigation of the mechanism of action of FoxM1 inhibitors revealed a novel mode of positive auto-regulation of FoxM1.
Related Compounds
Related Articles:
Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells.
2009-01-01
[PLoS ONE 4(5) , e5592, (2009)]
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer.
2013-02-01
[J. Mol. Med. 91(2) , 237-48, (2013)]
Two-dimensional NMR spectroscopy of siomycin A. Proton--carbon-13 chemical shift correlation.
1982-03-01
[Eur. J. Biochem. 123(1) , 127-31, (1982)]
FOXM1: the Achilles' heel of cancer?
2008-02-01
[Nat. Rev. Cancer 8(3) , c1; author reply c2, (2008)]
Future roles for FoxM1 inhibitors in cancer treatments.
2007-02-01
[Future Oncol. 3(1) , 1-3, (2007)]